AI 🤖 drug discovery companies already in clinical phase
“AI today isn’t ready to treat patients better. It is ready to accelerate the return on investment of drug discovery”. By Thomas Clozel, chief executive of Owkin
“Smart companies started generating their own data for the purposes of discovering new drugs.”
So far, in the traditional drug development process, things were more or less like this:
for every 10000 compounds screened 🕵️♀️ in the drug discovery phase,
approximately…